Claim: Nearly all children get sick from respiratory syncytial virus, or RSV, by the age of 2, and last year, there was a notable surge in RSV-associated hospitalizations. But the Food and Drug Administration is now considering approval of a vaccine and a monoclonal antibody aimed at protecting infants from this common virus.
Fact-check: Q&A on RSV Maternal Vaccine and Antibody Candidates to Protect Infants - FactCheck.org
Verdict: nearly all children get sick from respiratory syncytial virus, or rsv, by the age of 2, and last year, there was a notable surge in rsv-associated hospitalizations. but the food and drug administration is now considering approval of a vaccine and a monoclonal antibody aimed at protecting infants from this common virus.
Organisation: FactCheck.org
Author: Lori Robertson
Date published: 2023-03-23T19:34:14